The potential for targeting extracellular LOX proteins in human malignancy

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• The extracellular matrix (ECM) provides structural support for cells and tissues.
• ECM modifications are implicated in cancer progression, including proliferation, invasion, and metastasis.
• Lysyl oxidase (LOX) enzymes are key regulators of ECM cross-linking and maturation.

Purpose of the Study:

• To investigate the multifaceted roles of LOX enzymes in cancer progression.
• To highlight the involvement of LOX and LOX-like 2 in cancer metastasis.
• To underscore the need for context-dependent therapeutic strategies targeting the LOX family.

Main Methods:

• Review of existing literature on LOX enzymes and their function in cancer.
• Analysis of the dual role of LOX enzymes, considering both pro-cancer and anti-cancer effects.
• Examination of the impact of LOX enzymes on ECM composition and its relation to metastasis.

Main Results:

• LOX enzymes play a central role in ECM deposition and maturation.
• Specific LOX family members (LOX, LOX-like 2) are significantly linked to cancer metastasis.
• LOX enzyme activity can yield by-products with antiproliferative effects in certain cancers.
• The effect of LOX enzymes is dependent on the specific molecular network within the cancer.

Conclusions:

• Targeting the LOX family for cancer therapy requires careful consideration of the individual cancer's molecular characteristics.
• Therapies may need to combine agents that target both LOX enzymes and their associated molecular networks.
• Understanding the complex role of LOX in cancer is essential for developing effective anti-metastatic strategies.